Federico Paparcura

ORCID: 0009-0007-0881-7233
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Endometrial and Cervical Cancer Treatments
  • Ovarian cancer diagnosis and treatment
  • Sarcoma Diagnosis and Treatment
  • Uterine Myomas and Treatments
  • Pelvic floor disorders treatments
  • Pituitary Gland Disorders and Treatments
  • Cervical Cancer and HPV Research
  • PARP inhibition in cancer therapy
  • Anesthesia and Pain Management
  • Reconstructive Surgery and Microvascular Techniques
  • Corneal Surgery and Treatments
  • MRI in cancer diagnosis
  • Cardiac, Anesthesia and Surgical Outcomes
  • Nausea and vomiting management
  • Surgical Simulation and Training
  • Estrogen and related hormone effects
  • Wound Healing and Treatments
  • Patient Safety and Medication Errors

University of Udine
2022-2025

Ospedale Santa Maria della Misericordia di Udine
2024-2025

Molecular features are essential for estimating the risk of recurrence and impacting overall survival in patients with endometrial cancer. Additionally, surgical procedure itself could be personalized based on molecular characteristics tumor. This study aims to assess feasibility obtaining reliable classification status from biopsy specimens collected during hysteroscopy better modulate appropriate treatment.

10.1136/ijgc-2024-005478 article EN International Journal of Gynecological Cancer 2024-07-01

Background and Objectives: Robotic-assisted laparoscopy (RS) has been widely adopted for the management of endometrial cancer (EC) due to favorable perioperative outcomes, especially in context obesity, which is an established risk factor EC. This study retrospectively evaluated outcomes RS versus conventional (LS) treating EC atypical hyperplasia (AH). Methods: Between November 2021 October 2023, 138 patients with AH or underwent surgery at Clinic Obstetric Gynecological—Azienda Sanitaria...

10.3390/cancers17030482 article EN Cancers 2025-02-01

Abstract Objective The aim of this study was to compare postoperative outcomes in patients undergoing standard laparoscopic salpingo‐oophorectomy versus those using the MiniLap percutaneous surgical system, aiming demonstrate non‐inferiority ultra‐minimally invasive technique compared current gold standard. Methods This a retrospective, single‐center propensity‐matched case–control study. A total 80 for benign pathology were selected, with 40 each group (MiniLap and S‐LPS B). Postoperative...

10.1002/ijgo.70060 article EN cc-by International Journal of Gynecology & Obstetrics 2025-03-11

This study investigates the association between microsatellite instability (MSI) and risk of occult lymph node metastases (LNMs) in patients with early-stage endometrial cancer (EC) who showed no evidence nodal involvement on preoperative imaging. A retrospective multicenter cohort was conducted, including 237 EC underwent primary staging surgery January 2022 October 2024. The were stratified into two groups based MSI status. outcome prevalence LNMs. Statistical analyses included univariate...

10.3390/cancers17071162 article EN Cancers 2025-03-30

Abstract Background Perineal lacerations are a very common complication of post-partum. Usually, the repair 1st and 2nd-grade is performed after administration local anesthesia. Despite great relevance problem, there only few studies about best choice anesthetic to use during suturing. We randomised controlled trial evaluate efficacy safety spray suturing perineal in Methods compared with standard technique, which involves infiltration lacerated tissues, using NRS scale. 136 eligible women...

10.1186/s12884-024-06640-7 article EN cc-by BMC Pregnancy and Childbirth 2024-06-24

<h3>Introduction/Background</h3> Intermediate-high and high-risk endometrial cancer often require adjuvant treatments such as radiotherapy (RT) or brachytherapy to reduce loco-regional relapse risk. Inter- intra-fraction variability of pelvic anatomy are the largest source error affecting RT. The implantation Fiducial Makers (FMs) in vaginal cuff patients receiving could help patient daily setup, image guidance detection radiation targets. <h3>Methodology</h3> We evaluated an 80-year-old...

10.1136/ijgc-2024-esgo.288 article EN 2024-03-01

Uterine leiomyosarcoma is a rare malignant gynecologic tumor that arises from the myometrial or endometrial stromal precursor cells. This has highest prevalence in pre- and post-is more frequent between 40 60 years old. It very unfavorable prognosis: only early-stage tumors have an acceptable prognosis; unfortunately, it often diagnosed accidentally, typically on advanced stage, when hematological metastases already spread. Surgery main treatment strategy, while systemic radiotherapy are not...

10.23736/s2724-606x.22.05131-4 article EN Minerva Obstetrics and Gynecology 2024-04-01

The application of the amniotic membrane could have a favourable effect on tissue repair and regeneration. We report first case implant an in patient affected by myo-cutaneous dehiscence, after radical surgical treatment for vulvar cancer.We describe 74-years-old cancer. After radiotherapy, underwent to anterior pelvic exenteration with uretero-ileo-cutaneostomy Wallace, bilateral lymphadenectomy, omental biopsies, flap, inguinal resection ulcerated left lesion, reconstruction gracilis...

10.3389/fonc.2022.1009884 article EN cc-by Frontiers in Oncology 2022-09-23
Coming Soon ...